Holen Sie sich die Stockscreener-App
1.35
2.17%
-0.03
Handel nachbörslich:
1.35
Schlusskurs vom Vortag:
$1.38
Offen:
$1.33
24-Stunden-Volumen:
18,547
Relative Volume:
0.29
Marktkapitalisierung:
$75.23M
Einnahmen:
$118.18M
Nettoeinkommen (Verlust:
$5.99M
KGV:
10.24
EPS:
0.1319
Netto-Cashflow:
$-12.91M
1W Leistung:
-3.57%
1M Leistung:
-16.41%
6M Leistung:
-15.62%
1J Leistung:
-12.34%
1-Tages-Spanne:
$1.32
$1.35
1-Wochen-Bereich:
$1.32
$1.46
52-Wochen-Spanne:
$1.17
$1.79
Intercure Ltd Stock (INCR) Company Profile
Vergleichen Sie INCR mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
INCR
Intercure Ltd
|
1.35 | 75.23M | 118.18M | 5.99M | -12.91M | 0.1319 |
|
ZTS
Zoetis Inc
|
120.24 | 52.69B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.66 | 43.09B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.46 | 41.90B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
23.97 | 28.06B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
448.91 | 19.55B | 3.08B | 1.24B | 1.07B | 25.61 |
Intercure Ltd Stock (INCR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2022-05-18 | Hochstufung | Canaccord Genuity | Speculative Buy → Buy |
Intercure Ltd Aktie (INCR) Neueste Nachrichten
Does InterCure Ltd. stock trade at a discount to peers2025 EndofYear Setup & Free Fast Gain Swing Trade Alerts - newser.com
Is InterCure Ltd. stock a buy in volatile marketsMarket Growth Report & Risk Managed Investment Entry Signals - newser.com
Analyzing drawdowns of InterCure Ltd. with statistical toolsJuly 2025 Drop Watch & Free Community Supported Trade Ideas - newser.com
Can InterCure Ltd. stock beat market expectations this quarterChart Signals & Free Accurate Trade Setup Notifications - newser.com
Why InterCure Ltd. stock attracts global investorsCEO Change & Smart Allocation Stock Reports - newser.com
Will InterCure Ltd. stock outperform international peersMarket Activity Summary & Breakout Confirmation Trade Signals - newser.com
Technical signs of recovery in InterCure Ltd.July 2025 Opening Moves & Intraday High Probability Alerts - newser.com
Will InterCure Ltd. stock recover after recent drop2025 Fundamental Recap & AI Based Buy and Sell Signals - newser.com
Can swing trading help recover from InterCure Ltd. lossesBull Run & Daily Stock Momentum Reports - newser.com
Using data models to predict InterCure Ltd. stock movementJuly 2025 Catalysts & Weekly Chart Analysis and Guides - newser.com
Is InterCure Ltd. stock recession proofRate Cut & Real-Time Volume Trigger Notifications - newser.com
How InterCure Ltd. stock benefits from tech adoptionPortfolio Gains Report & Daily Technical Forecast Reports - newser.com
News impact scoring models applied to InterCure Ltd.2025 Sector Review & Fast Exit/Entry Strategy Plans - newser.com
Real time scanner hits for InterCure Ltd. explainedMarket Rally & Long-Term Safe Investment Ideas - newser.com
What sentiment indicators say about InterCure Ltd. stockTrade Performance Summary & Growth Focused Stock Pick Reports - newser.com
InterCure acquires 28% stake in cannabis research firm Cannasoul By Investing.com - Investing.com Australia
Will InterCure Ltd. price bounce be sustainableEarnings Trend Report & Weekly High Return Forecasts - newser.com
Is InterCure Ltd. stock cheap at current valuationEarnings Overview Report & AI Forecasted Entry and Exit Points - newser.com
Does InterCure Ltd. qualify in momentum factor screeningMarket Activity Summary & Low Risk High Win Rate Stock Picks - newser.com
What technical models suggest about InterCure Ltd.’s comebackJuly 2025 Retail & AI Forecasted Entry and Exit Points - newser.com
Is it time to cut losses on InterCure Ltd.Weekly Trade Review & Daily Oversold Stock Bounce Ideas - newser.com
Volatility clustering patterns for InterCure Ltd.Bear Alert & Daily Market Momentum Tracking - newser.com
InterCure acquires 28% stake in cannabis research firm Cannasoul - Investing.com
InterCure and Cannasoul Forge Strategic Partnership to Innovate Cannabis Therapeutics - TipRanks
InterCure Ltd. Enters into A Collaboration Agreement with Cannasoul R&D Ltd - MarketScreener
InterCure and Cannasoul Sign Strategic Investment and Collaboration Agreements to Advance Cannabis Science and Pharmaceutical Innovation - The Manila Times
Applying Wyckoff theory to InterCure Ltd. stockJuly 2025 PostEarnings & Technical Pattern Alert System - newser.com
InterCure (NASDAQ: INCR) signs Cannasoul collaboration; 28% stake, path to 51% - Stock Titan
What technical charts say about InterCure Ltd. stockPortfolio Growth Summary & High Accuracy Swing Entry Alerts - newser.com
Finanzdaten der Intercure Ltd-Aktie (INCR)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.18%
0.10%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):